FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a new group of 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1(2H)-one O-(aminoalkyl)oximes synthesised at the interaction of 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1(2H)-one oxime with aminoalkylhalides in the presence of sodium hydride.
EFFECT: production of new 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1(2H)-ones O-(aminoalkyl)oximes with a pronounced anticonvulsant effect.
4 cl, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
CINNAMOYL DERIVATIVES OF DIBENZOFURANONE OXIME WITH ANTICONVULSANT ACTIVITY | 2023 |
|
RU2810250C1 |
DIBENZOFURAN OXIME DERIVANTS WITH ANTICONVULSANT AND NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2744758C2 |
DRUG FOR IMPROVING BLOOD SUPPLY OF ISCHEMIZED BRAIN | 2019 |
|
RU2747202C2 |
4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
COUMARIN, THIOCOUMARIN AND QUINOLINONE DERIVATIVES, HAVING ANTICONVULSANT ACTIVITY | 2017 |
|
RU2720510C2 |
DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
ANTICONVULSANT AND TRANQUILISING AGENT | 2015 |
|
RU2593885C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
3-BENZYLAMINOMETHYLENEPYRROLIDINE-2,4-DIONE AND ANTICONVULSANT AGENT BASED ON SAID | 1997 |
|
RU2144918C1 |
N,N-DI- (BENZHYDRYL) -N-(TRIFLUOROACETYL)- UREAS SHOWING ANTICONVULSANT AND ENZYME-INDUCING ACTIVITY | 1991 |
|
RU2024501C1 |
Authors
Dates
2022-05-30—Published
2020-10-28—Filed